| Viral vectors and extracellular vesicles: Innate delivery systems utilized in CRISPR/Cas-mediated cancer therapy SE Ahmadi, M Soleymani, F Shahriyary, MR Amirzargar, M Ofoghi, ... Cancer Gene Therapy 30 (7), 936-954, 2023 | 21 | 2023 |
| Natural killer cells in COVID-19: from infection, to vaccination and therapy A Zafarani, MH Razizadeh, S Pashangzadeh, MR Amirzargar, ... Future virology 18 (3), 177-191, 2023 | 15 | 2023 |
| The role of NK cells and their exosomes in graft versus host disease and graft versus leukemia A Zafarani, M Taghavi-Farahabadi, MH Razizadeh, MR Amirzargar, ... Stem Cell Reviews and Reports 19 (1), 26-45, 2023 | 6 | 2023 |
| Bleeding disorder of unknown cause: results from Iranian study A Zafarani, E Ghodratnia, MR Amirzargar, M Mahmoudi, ... Transfusion and Apheresis Science 62 (5), 103730, 2023 | 1 | 2023 |
| Angiogenesis, coagulation, and fibrinolytic markers in acute promyelocytic leukemia (NB4): An evaluation of melatonin effects MR Amirzargar, F Shahriyary, M Shahidi, A Kooshari, M Vafajoo, ... Journal of Pineal Research, 2023 | 1 | 2023 |
| The impact of neutrophil extracellular traps in coronavirus disease-2019 pathophysiology M Shahidi, MR Amirzargar Blood Coagulation & Fibrinolysis 34 (2), 87-92, 2023 | 1 | 2023 |
| Gynecological Bleeding in Women with Congenital Bleeding Disorders: A Comprehensive Cohort from Iran A Zafarani, E Ghodratnia, MR Amirzargar, Y Poriafar, S Tabibian Transfusion and Apheresis Science, 103941, 2024 | | 2024 |
| Resveratrol and tetrahydroisoquinoline effects on neutrophil sensitivity to NETosis formation in low‐risk essential thrombocythemia patients F Shahriyary, MR Amirzargar, M Vafajoo, A Kooshari, A Basi, SM Razavi, ... European Journal of Haematology, 2024 | | 2024 |
